Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

U.S. Rep. Michael C. Burgess, M.D., hosts roundtable at UT Southwestern to discuss pivotal 21st Century Cures Act and future of biomedical science


News provided by

UT Southwestern Medical Center

Sep 01, 2015, 12:30 ET

Share this article

Share toX

Share this article

Share toX

DALLAS, Sept. 1, 2015 /PRNewswire-USNewswire/ -- UT Southwestern Medical Center President Dr. Daniel K. Podolsky and distinguished faculty members joined U.S. Representatives Michael C. Burgess, M.D., and Joe Barton in a roundtable discussion on the 21st Century Cures Act, bipartisan legislation in support of biomedical research currently being considered by the United States Senate.

UT Southwestern faculty – including National Academy of Sciences members, department chairs, center directors, and leading researchers – joined residents and students at the event, which included a tour of the Hamon Center for Regenerative Science and Medicine and a technology demonstration at UT Southwestern's recently opened William P. Clements Jr. University Hospital.

Dr. Burgess, R-Texas, a former resident at UT Southwestern, is an architect and co-sponsor of the legislation. The legislation would establish an Innovation Fund at the National Institutes of Health (NIH) to renew federal support and funding for biomedical research, which has declined more than 22 percent in inflation-adjusted dollars since 2003. The legislation also would set new guidelines for more expeditious FDA approvals of drugs and medical devices. The U.S. House of Representatives approved the 21st Century Cures Act with a vote of 344-77.

"It is crucial that America remains at the front lines of biomedical research and care. These investments lead to exponential advances in medicine," said Dr. Burgess, an Ob-Gyn. "Today's event at UT Southwestern offered an exceptional look into the high caliber of people and the effort involved in finding new cures. We cannot allow our lofty, yet achievable goals, to be lost amid the political discourse. What if that cure is within our grasp, sitting in a test tube in one of these labs, just waiting for us to finish our analysis?"

Dr. Burgess, Rep. Barton, and Dr. Podolsky were joined by UT Southwestern roundtable participants:

  • J. Gregory Fitz, M.D., FAASLD – Executive Vice President for Academic Affairs and Provost;  Dean, UT Southwestern Medical School;
  • David W. Russell, Ph.D. – National Academy of Sciences Member; Vice Provost and Dean of Basic Research;
  • Steven McKnight, Ph.D. – National Academy of Sciences Member; Professor and Chair, Biochemistry;
  • Eric Olson, Ph.D. – National Academy of Sciences Member; Professor and Chair, Molecular Biology; Director, Hamon Center for Regenerative Science and Medicine;
  • Helen H. Hobbs, M.D. – National Academy of Sciences Member; Professor, Internal Medicine and Molecular Genetics; Director, Eugene McDermott Center for Human Growth & Development;
  • Marc Diamond, M.D. – Professor, Neurology & Neurotherapeutics, Neuroscience; Director, Center for Alzheimer's and Neurodegenerative Diseases;
  • James de Lemos, M.D. – Professor, Internal Medicine; Associate Program Director, Cardiology Fellowship Program;
  • Christine K. Garcia, M.D., Ph.D. – Associate Professor, Eugene McDermott Center for Human Growth & Development, and Internal Medicine - Pulmonary Division; Director, Human Genetics Clinical Core; and
  • Suresh Gunasekaran, UT Southwestern Associate Vice President for Health System Management Services.

"Biomedical research is of critical and fundamental importance to Texas, the nation, and, most importantly, to all those struggling with disease," said Dr. Podolsky. "This research includes developing a better understanding of the basic causes and mechanisms that lead to disease, as well as new and more effective therapies made possible by those insights. Groundbreaking research offers the best hope for improving the health of all people."

"We deeply appreciate Dr. Burgess' and Rep. Barton's leadership in advancing the important role of academic medical centers and other institutions in finding better therapies and new cures," added Dr. Podolsky, who holds the Philip O'Bryan Montgomery, Jr., M.D. Distinguished Presidential Chair in Academic Administration, and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science.

Rep. Barton, R-Texas, noted, "There are things in the 21st Century Cures Act that I have worked on for 10 years, things that will help find cures sooner rather than later. I'm tired of telling parents of sick children: 'I can't help you.' This bill is something we can all be proud of. We can now tell parents and others battling disease there is hope. There is a future!

"The work being done at UT Southwestern is going to be a part of that future. I look forward to seeing the discoveries made here."

Following the roundtable discussion with UT Southwestern's medical experts, Dr. Burgess and others toured the Hamon Center for Regenerative Science and Medicine, made possible by a $10 million endowment gift from the Hamon Charitable Foundation. The Center's goal is to understand the basic mechanisms for tissue and organ formation, and then to use that knowledge to regenerate, repair, and replace tissues damaged by aging or injury.

Recently, regenerative medicine researchers at UT Southwestern identified a cell that replenishes adult heart muscle. Researchers have been trying for decades to find the specialized cells that make new muscle cells in the adult heart, because most of these types of cells don't replenish themselves after a heart attack or other significant heart muscle damage. UT Southwestern researchers were able to devise a new cell-tracing technique, allowing them to detect cells that do replenish themselves after being damaged. The research was funded in part by grants from the NIH.

Other research at UT Southwestern that was funded by the NIH includes the development of a drug that has the potential to prevent malaria in a single dose, work leading to a new class of cholesterol-lowering drugs that were recently approved by the FDA, and a vaccine for Alzheimer's disease.

"These projects showcase the importance of NIH funding for studies that have great potential to improve health here and abroad," Dr. Podolsky said. "The projects also demonstrate the value of combining NIH funds with other state, federal, and private monies – multiplying the impact. But research is just the beginning. The amount of time it takes to translate research into therapies that help patients is directly related to congressional support for legislation such as the 21st Century Cures Act."

During his visit to UT Southwestern, Dr. Burgess also met with residents at Clements University Hospital, UT Southwestern's new 460-room, $800 million hospital that opened in December 2014. The hospital is specifically designed to not only meet the needs of patients, but to serve as a state-of-the-art teaching facility. The Congressman's visit included a demonstration of advanced technologies linking patient, operating, and education rooms, which expands opportunities for learning.

"The innovative technologies, educational opportunities, and advanced research and clinical care that we saw today at UT Southwestern illustrate how much we all depend on research and the quality health care it supports," Dr. Burgess said. "The 21st Century Cures Act is an opportunity to promote discovery and deliver the cures so many of our citizens are hoping for."

About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of more than 2,700 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to about 92,000 hospitalized patients and oversee approximately 2.1 million outpatient visits a year.

This news release is available on our home page at
www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via email, subscribe at www.utsouthwestern.edu/receivenews

SOURCE UT Southwestern Medical Center

Related Links

http://www.utsouthwestern.edu/home_pages/news/

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.